Literature DB >> 26306619

Expanding the role of the splicing USB1 gene from Poikiloderma with Neutropenia to acquired myeloid neoplasms.

Gloria Negri1, Barbara Crescenzi2, Elisa Adele Colombo1, Laura Fontana1, Gianluca Barba2, Francesco Arcioni3, Cristina Gervasini1, Cristina Mecucci2, Lidia Larizza4.   

Abstract

Germline mutations of the U6 biogenesis 1 (USB1) gene underlie Poikiloderma with Neutropenia (PN), a rare autosomal recessive genodermatosis conferring an increased risk of myelodysplasia. Recent evidence highlights a key role of USB1 protein in the splicing process, but nothing is known about USB1 alterations in acquired myelodysplastic syndromes, even though mutations in the spliceosome machinery represent an ubiquitous pathway in leukaemogenesis. By molecular cytogenetics and direct sequencing, we searched for USB1 deletions/duplications and point mutations in 141 bone marrow DNA samples from patients with myelodysplastic syndromes (n = 126), myelodysplastic/myeloproliferative neoplasms (n = 12) and acute myeloid leukaemia (n = 3). Three unreported variants, two in USB1 5'UTR (c.-83G>T and c.-66A>G), one in IVS3 (c.450-68dupT) and one (<1%) in IVS4 (c.587+21A>G/rs200924980) were detected. The germline nature could be proved for the c.-66A>G, but remains undefined for c.-83G>T and c.450-68dupT. Matched controls analysis did not reveal either 5' UTR variants in 290 chromosomes and Real-time polymerase chain reaction showed a slight reduction in bone marrow RNA levels of the patient with c.-66A>G. No USB1 rearrangements were detected by interphase fluorescence in situ hybridization. This pilot investigation on USB1 expanded the variations repertoire of this gene, identifying three novel sequence variants, the role of which need further investigations in myeloid malignancies.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  USB1 point mutations; USB1 rearrangements; USB1 susceptibility variants to myeloid malignancies; myelodysplastic syndrome

Mesh:

Substances:

Year:  2015        PMID: 26306619     DOI: 10.1111/bjh.13651

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Diagnosis and therapeutic decision-making for the neutropenic patient.

Authors:  James A Connelly; Kelly Walkovich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Variant snRNPs: New players within the spliceosome system.

Authors:  Pilar Vazquez-Arango; Dawn O'Reilly
Journal:  RNA Biol       Date:  2017-10-11       Impact factor: 4.652

3.  The Role of Genetic Testing in Hereditary Poikiloderma: A Case Report.

Authors:  Sarah El-Heis; Keith M Godfrey
Journal:  Glob Pediatr Health       Date:  2017-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.